HealthControversial Aduhelm Alzheimer Drug's Quick Approval To Be Reviewed: US HHS Now Questions FDA's Decision U.S. HHS will investigate the controversial Aduhelm drug after FDA quickly approved Alzheimer's medicine.by Griffin Davis
TechDrunk-Driving Identifier Tech Could Identify If Blood Alcohol Concentration Exceeds Legal Limitationby Griffin Davis
Culture#BoycottPokemonGO: Most High Profile Players Release Open Letter To Niantic—They Want Extended Interaction Range To Remainby Griffin Davis
HealthTikTok's Latest Trend Called 'Frozen Honey' Challenge Can Give You Diarrhea, Experts Warnby Sophie Webster
TechApple App Store Promotes Scam Applications, Mistakenly? Some of Them Even Have More Than $10 Weekly Fee: How To Know If It's Fakeby Griffin Davis
TechBiden EV Goal To Produce Electric Cars by 2030: GM, Ford, Stellantis, and Other Automakers To Support US President’s Initiativeby Griffin Davis
TechTwitter-Based NFTs Seller, CENT, Acquires $3 Million Funding From Disney, Will.I.Am, Zynga, and MORE!by Griffin Davis